A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2017
At a glance
- Drugs ABT 122 (Primary) ; Adalimumab
- Indications Psoriatic arthritis
- Focus Therapeutic Use
- Sponsors AbbVie
- 13 Jul 2016 Status changed from active, no longer recruiting to completed.
- 09 Jul 2016 The trial is completed in Hungary (End date:2016-07-01) as per European Clinical Trials Database record.
- 12 May 2016 The trial is completed in Germany and Czech republic as per European Clinical Trials Database record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History